<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Innovative Designs | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20211021innovative-designs/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/tag/20211021innovative-designs/index.xml" rel="self" type="application/rss+xml" />
    <description>Innovative Designs</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Thu, 21 Oct 2021 06:00:00 -0700</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>Innovative Designs</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20211021innovative-designs/</link>
    </image>
    
    <item>
      <title>Joint PSI, EFSPI and ASA BIOP Webinar - Complex Innovative Designs</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20211021joint-psi-efspi-asa-biop-webinar-complex-innovative-designs/</link>
      <pubDate>Thu, 21 Oct 2021 06:00:00 -0700</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20211021joint-psi-efspi-asa-biop-webinar-complex-innovative-designs/</guid>
      <description>&lt;p&gt;PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Complex Innovative Designs (CID) in practice.  Speakers from regulatory authorities and industry will present on their experience, which will include the following aspects:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Overview of the FDA Complex Innovative Trial Design pilot program and the applications received to date together with details on some of them&lt;/li&gt;
&lt;li&gt;Overview of the FDA guidance on interacting on Complex Innovative Trial Designs&lt;/li&gt;
&lt;li&gt;Detailed case study of a clinical trial in children which was evaluated within FDAâ€™s CID pilot program, applying borrowing of information from external trials in adults&lt;/li&gt;
&lt;li&gt;Overview of statistical and regulatory considerations on master protocols, focusing on Phase III confirmatory trials.&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
  </channel>
</rss>
